Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Altarex receives funding for photodynamic therapy for ovarian cancer research

April 28, 1997

Bioniche reports positive clinical results for Regressin

April 25, 1997

BTG licenses Campath-1H to LeukoSite

April 25, 1997

Cel-Sci initiates clinical trial of Multikine in Israel

April 24, 1997

Medarex presents MDX-220 preclinical data at AACR

April 21, 1997

Supplemental BLA submitted in U.S. for Proleukin

April 16, 1997

Antitumor activity of Ono-4007 related to TNF induction

April 7, 1997

CAT and Techniclone to initiate trials for tumor therapy

March 27, 1997

Bristol-Myers Squibb discovers new ribosome-inactivating protein

March 27, 1997

Multikine trial approved in Israel

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...